Guido Tricot, MD, PhD, is a professor in the Department of Medicine at the University of Utah School of Medicine. He is also a physician and investigator at Huntsman Cancer Institute, director of the Utah Blood and Marrow Transplant and Myeloma Program, and member of the Imaging, Diagnostics, and Therapeutics Program.

Tricot’s major interest is in multiple myeloma. His team’s treatment strategies are based on tandem autologous transplantation. In this technique, a patient receives two self-donated stem cell transplants within a short period of time. The team’s most recent studies focus on not only attacking myeloma cells but also the micro-environment which supports the survival and growth of myeloma cells. Research aims toward finding treatments that are non-cross-resistant with chemotherapy (mainly immunologic based on NK cells) and also towards individualizing therapies to ensure proper levels of treatment. Over the last 15 years, the median survival for patients newly diagnosed with myeloma has increased from 2.5 to 10 years.

Tricot received his medical and doctoral degrees from the University of Leuven in Belgium. Before joining Huntsman Cancer Institute, he was director of clinical research at the University of Arkansas Myeloma Institute for Research and Therapy. This was the largest myeloma program in the world, treating approximately 650 new myeloma patients per year.